We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
83 hedge funds and large institutions have $65.5M invested in Puma Biotechnology in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 21 increasing their positions, 29 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
698% more call options, than puts
Call options by funds: $1.07M | Put options by funds: $134K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.31% less ownership
Funds ownership: 62.01% → 60.7% (-1.3%)
6% less funds holding
Funds holding: 88 → 83 (-5)
13% less capital invested
Capital invested by funds: $75.2M → $65.5M (-$9.72M)
28% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 29
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
Holders
83
Holders Change
-5
Holders Change %
-5.68%
% of All Funds
1.43%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
21
Reduced
29
Closed
14
Calls
$1.07M
Puts
$134K
Net Calls
+$935K
Net Calls Change
+$865K
Top Buyers
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$1.46M |
| 2 |
D.E. Shaw & Co
New York
|
-$1.23M |
| 3 |
Renaissance Technologies
New York
|
-$518K |
| 4 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$346K |
| 5 |
Goldman Sachs
New York
|
-$296K |
